Lonza Group Ag Debt Issuance/Retirement Net - Total 2012-2024 | LZAGY

Lonza Group Ag annual/quarterly debt issuance/retirement net - total history and growth rate from 2012 to 2024. Debt issuance/retirement net - total can be defined as the total amount of short term and long term borrowings repaid and issued.
  • Lonza Group Ag debt issuance/retirement net - total for the quarter ending December 31, 2024 was $2.181B, a 15142.96% decline year-over-year.
  • Lonza Group Ag debt issuance/retirement net - total for the twelve months ending December 31, 2024 was $3.775B, a 1272.91% decline year-over-year.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2023 was $0.908B, a 508.65% decline from 2022.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2022 was $-0.222B, a 54.58% decline from 2021.
  • Lonza Group Ag annual debt issuance/retirement net - total for 2021 was $-0.489B, a 469.78% decline from 2020.
Lonza Group Ag Annual Debt Issuance/Retirement Net - Total
(Millions of US $)
2023 $908
2022 $-222
2021 $-489
2020 $132
2019 $-482
2017 $121
2016 $-135
2015 $-129
2014 $2
2013 $-1
2012 $324
2011 $426
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $50.609B $7.468B
Lonza Group AG operates as a supplier to the pharmaceutical, healthcare and life-science industries. The Company divides its activities into four divisions: Life Science Ingredients; Microbial Control; Custom Manufacturing, and Bioscience. The company's Life Science Ingredients segment produces nutrition ingredients for applications in nutrition (food, feed and pharmaceutical application) and chemical intermediates for the agricultural industry. The Microbial Control division focuses on five areas: hygiene, wood protection, water treatment, oil/gas applications, and industrial preservation and comprises products ranging from disinfectants to household cleaning products. The Custom Manufacturing division comprises products used in pharmaceuticals sector. The Bioscience division comprises bioscience products, including cell culture and molecular biology tools for research, tests for microbial detection, and media used in the production of therapeutics. Lonza Group AG is headquartered in Basel, Switzerland.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $233.904B 28.13
Boston Scientific (BSX) United States $154.336B 38.64
Stryker (SYK) United States $150.874B 31.55
EssilorLuxottica (ESLOY) France $127.819B 0.00
Medtronic (MDT) Ireland $113.364B 16.07
Haleon (HLN) United Kingdom $46.066B 26.28
ResMed (RMD) United States $37.677B 28.30
GE HealthCare Technologies (GEHC) United States $34.831B 16.54
Agilent Technologies (A) United States $34.480B 22.48
Terumo (TRUMY) Japan $25.244B 32.79
Koninklijke Philips (PHG) Netherlands $23.274B 16.33
Insulet (PODD) United States $21.186B 83.16
Zimmer Biomet Holdings (ZBH) United States $18.532B 11.90
Baxter (BAX) United States $15.914B 11.88
Smith & Nephew SNATS (SNN) United Kingdom $13.262B 0.00
Demant (WILYY) Denmark $8.971B 0.00
Sunny Optical Technology (SNPTF) China $8.561B 0.00
Bio-Rad Laboratories (BIO) United States $6.846B 23.82
Lantheus Holdings (LNTH) United States $5.564B 14.03
Prestige Consumer Healthcare (PBH) United States $3.952B 17.66
Perrigo (PRGO) Ireland $3.739B 9.48
Haemonetics (HAE) United States $3.693B 16.82
Shandong Weigao Medical Polymer (SHWGF) China $3.459B 0.00
Envista Holdings (NVST) United States $3.456B 28.72
ICU Medical (ICUI) United States $3.333B 24.58
QuidelOrtho (QDEL) United States $2.042B 14.04
LeMaitre Vascular (LMAT) United States $1.907B 42.62
AtriCure (ATRC) United States $1.572B 0.00
Acuren (TIC) United States $1.378B 0.00
AdaptHealth (AHCO) United States $1.258B 12.77
Green Thumb Industries (GTBIF) United States $1.164B 26.19
Neogen (NEOG) United States $1.157B 14.81
Phibro Animal Health (PAHC) United States $1.135B 14.51
BioLife Solutions (BLFS) United States $1.085B 0.00
InMode (INMD) Israel $0.958B 9.66
Kestra Medical Technologies (KMTS) United States $0.805B 0.00
Owens & Minor (OMI) United States $0.712B 5.90
CeriBell (CBLL) United States $0.684B 0.00
Maravai LifeSciences Holdings (MRVI) United States $0.680B 0.00
Evolus (EOLS) United States $0.598B 0.00
Curaleaf Holdings (CURLF) Canada $0.555B 0.00
Tilray Brands (TLRY) Canada $0.542B 0.00
Valneva SE (VALN) France $0.494B 0.00
Capricor Therapeutics (CAPR) United States $0.468B 0.00
Surmodics (SRDX) United States $0.429B 0.00
VAREX IMAGING (VREX) United States $0.363B 13.33
SEMPERIT AG HLD (SEIGY) Austria $0.360B 0.00
Quanterix (QTRX) United States $0.349B 0.00
SNDL (SNDL) Canada $0.334B 0.00
Cerus (CERS) United States $0.294B 0.00
ZimVie (ZIMV) United States $0.285B 12.98
Viemed Healthcare (VMD) United States $0.283B 23.83
Sanuwave Health (SNWV) United States $0.271B 0.00
Sanara MedTech (SMTI) United States $0.264B 0.00
Aurora Cannabis (ACB) Canada $0.255B 75.67
Brainsway (BWAY) Israel $0.250B 66.20
Cresco Labs (CRLBF) United States $0.246B 0.00
Canopy Growth (CGC) Canada $0.235B 0.00
Biote (BTMD) United States $0.231B 6.49
OraSure Technologies (OSUR) United States $0.230B 0.00
TriSalus Life Sciences (TLSI) United States $0.192B 0.00
Organigram Global (OGI) Canada $0.192B 0.00
Utah Medical Products (UTMD) United States $0.190B 15.46
High Tide (HITI) Canada $0.188B 0.00
Omeros (OMER) United States $0.188B 0.00
Verano Holdings (VRNOF) United States $0.177B 0.00
Exagen (XGN) United States $0.150B 0.00
Vireo Growth (VREOF) United States $0.144B 0.00
FitLife Brands (FTLF) United States $0.133B 16.35
Jin Medical (ZJYL) China $0.100B 0.00
Fonar (FONR) United States $0.097B 12.48
MacroGenics (MGNX) United States $0.092B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Veru (VERU) United States $0.089B 0.00
Apyx Medical (APYX) United States $0.087B 0.00
TerrAscend (TSNDF) Canada $0.084B 0.00
Quipt Home Medical (QIPT) United States $0.077B 0.00
Zynex (ZYXI) United States $0.073B 0.00
InterCure (INCR) Israel $0.071B 0.00
Cytosorbents (CTSO) United States $0.068B 0.00
Agape ATP (ATPC) $0.068B 0.00
Jushi Holdings (JUSHF) United States $0.063B 0.00
ImmuCell (ICCC) United States $0.058B 0.00
Nephros (NEPH) United States $0.043B 57.57
Modular Medical (MODD) United States $0.040B 0.00
United-Guardian (UG) United States $0.037B 12.86
Safety Shot (SHOT) United States $0.030B 0.00
Rockwell Medical (RMTI) United States $0.028B 0.00
Allurion Technologies (ALUR) United States $0.019B 0.00
INLIF (INLF) $0.016B 0.00
Meihua Medical Technologies (MHUA) China $0.014B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
Flora Growth (FLGC) United States $0.013B 0.00
IM Cannabis (IMCC) Canada $0.012B 0.00
Senestech (SNES) United States $0.012B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
Innovative Eyewear (LUCY) United States $0.007B 0.00
GlucoTrack (GCTK) United States $0.003B 0.00
Akanda (AKAN) Canada $0.002B 0.00
Sharps Technology (STSS) United States $0.000B 0.00
InVivo Therapeutics Holdings (NVIVQ) United States $0.000B 0.00